131 related articles for article (PubMed ID: 9341125)
1. UDP-glucuronosyltransferase, the role of the amino terminus in dimerization.
Meech R; Mackenzie PI
J Biol Chem; 1997 Oct; 272(43):26913-7. PubMed ID: 9341125
[TBL] [Abstract][Full Text] [Related]
2. Determinants of UDP glucuronosyltransferase membrane association and residency in the endoplasmic reticulum.
Meech R; Mackenzie PI
Arch Biochem Biophys; 1998 Aug; 356(1):77-85. PubMed ID: 9681994
[TBL] [Abstract][Full Text] [Related]
3. Hetero-oligomer formation of mouse UDP-glucuronosyltransferase (UGT) 2b1 and 1a1 results in the gain of glucuronidation activity towards morphine, an activity which is absent in homo-oligomers of either UGT.
Miyauchi Y; Kurita A; Yamashita R; Takamatsu T; Ikushiro S; Mackenzie PI; Tanaka Y; Ishii Y
Biochem Biophys Res Commun; 2020 Apr; 525(2):348-353. PubMed ID: 32093886
[TBL] [Abstract][Full Text] [Related]
4. Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes.
Ikushiro S; Emi Y; Iyanagi T
Biochemistry; 1997 Jun; 36(23):7154-61. PubMed ID: 9188715
[TBL] [Abstract][Full Text] [Related]
5. The interactions between the N-terminal and C-terminal domains of the human UDP-glucuronosyltransferases are partly isoform-specific, and may involve both monomers.
Kurkela M; Hirvonen J; Kostiainen R; Finel M
Biochem Pharmacol; 2004 Dec; 68(12):2443-50. PubMed ID: 15548391
[TBL] [Abstract][Full Text] [Related]
6. Expression and characterization of recombinant human UDP-glucuronosyltransferases (UGTs). UGT1A9 is more resistant to detergent inhibition than other UGTs and was purified as an active dimeric enzyme.
Kurkela M; García-Horsman JA; Luukkanen L; Mörsky S; Taskinen J; Baumann M; Kostiainen R; Hirvonen J; Finel M
J Biol Chem; 2003 Feb; 278(6):3536-44. PubMed ID: 12435745
[TBL] [Abstract][Full Text] [Related]
7. Structure/function of the human Ga1beta1,3-glucuronosyltransferase. Dimerization and functional activity are mediated by two crucial cysteine residues.
Ouzzine M; Gulberti S; Netter P; Magdalou J; Fournel-Gigleux S
J Biol Chem; 2000 Sep; 275(36):28254-60. PubMed ID: 10842173
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the carboxy-terminal region of UDP-glucuronosyltransferase 2B1.
Meech R; Yogalingam G; Mackenzie PI
DNA Cell Biol; 1996 Jun; 15(6):489-94. PubMed ID: 8672245
[TBL] [Abstract][Full Text] [Related]
9. Inter-isoform Hetero-dimerization of Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A9, and 2B7 and Impacts on Glucuronidation Activity.
Yuan LM; Gao ZZ; Sun HY; Qian SN; Xiao YS; Sun LL; Zeng S
Sci Rep; 2016 Nov; 6():34450. PubMed ID: 27857056
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac.
King C; Tang W; Ngui J; Tephly T; Braun M
Toxicol Sci; 2001 May; 61(1):49-53. PubMed ID: 11294973
[TBL] [Abstract][Full Text] [Related]
11. Purification of a phenobarbital-inducible UDP-glucuronosyltransferase isoform from dog liver which catalyzes morphine and testosterone glucuronidation.
Oguri K; Kurogi A; Yamabe K; Tanaka M; Yoshisue K; Ishii Y; Yoshimura H
Arch Biochem Biophys; 1996 Jan; 325(2):159-66. PubMed ID: 8561493
[TBL] [Abstract][Full Text] [Related]
12. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
[TBL] [Abstract][Full Text] [Related]
13. Determination of the human liver UDP-glucuronosyltransferase 2B4 domains involved in the binding of UDP-glucuronic acid using photoaffinity labeling of fusion proteins.
Pillot T; Ouzzine M; Fournel-Gigleux S; Lafaurie C; Tebbi D; Treat S; Radominska A; Lester R; Siest G; Magdalou J
Biochem Biophys Res Commun; 1993 Dec; 197(2):785-91. PubMed ID: 8267616
[TBL] [Abstract][Full Text] [Related]
14. Function of conserved aromatic residues in the Gal/GalNAc-glycosyltransferase motif of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1.
Tenno M; Saeki A; Elhammer AP; Kurosaka A
FEBS J; 2007 Dec; 274(23):6037-45. PubMed ID: 17970754
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional studies of UDP-glucuronosyltransferases.
Radominska-Pandya A; Czernik PJ; Little JM; Battaglia E; Mackenzie PI
Drug Metab Rev; 1999 Nov; 31(4):817-99. PubMed ID: 10575553
[TBL] [Abstract][Full Text] [Related]
16. Human UDP-glucuronosyltransferase expression in insect cells: ratio of active to inactive recombinant proteins and the effects of a C-terminal his-tag on glucuronidation kinetics.
Zhang H; Patana AS; Mackenzie PI; Ikushiro S; Goldman A; Finel M
Drug Metab Dispos; 2012 Oct; 40(10):1935-44. PubMed ID: 22782802
[TBL] [Abstract][Full Text] [Related]
17. Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).
Ghosh SS; Lu Y; Lee SW; Wang X; Guha C; Roy-Chowdhury J; Roy-Chowdhury N
Biochem J; 2005 Dec; 392(Pt 3):685-92. PubMed ID: 16171463
[TBL] [Abstract][Full Text] [Related]
18. Purification and properties of two rat liver phenobarbital-inducible UDP-glucuronosyltransferases that catalyze the glucuronidation of opioids.
Coffman BL; Rios GR; Tephly TR
Drug Metab Dispos; 1996 Mar; 24(3):329-33. PubMed ID: 8820424
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous expression of guinea pig UDP-glucuronosyltransferase 2B21 and 2B22 in COS-7 cells enhances UDP-glucuronosyltransferase 2B21-catalyzed morphine-6-glucuronide formation.
Ishii Y; Miyoshi A; Watanabe R; Tsuruda K; Tsuda M; Yamaguchi-Nagamatsu Y; Yoshisue K; Tanaka M; Maji D; Ohgiya S; Oguri K
Mol Pharmacol; 2001 Nov; 60(5):1040-8. PubMed ID: 11641432
[TBL] [Abstract][Full Text] [Related]
20. Arginine 52 and histidine 54 located in a conserved amino-terminal hydrophobic region (LX2-R52-G-H54-X3-V-L) are important amino acids for the functional and structural integrity of the human liver UDP-glucuronosyltransferase UGT1*6.
Senay C; Ouzzine M; Battaglia E; Pless D; Cano V; Burchell B; Radominska A; Magdalou J; Fournel-Gigleux S
Mol Pharmacol; 1997 Mar; 51(3):406-13. PubMed ID: 9058595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
